|
|
|
Insider
Information: |
Murray Richard /ca/ |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
70,160 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$173,295 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
70,160 |
|
|
Total
Value |
$173,295 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
137.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PDL Biopharma Inc |
PDLI |
EVP & CSO |
2008-07-21 |
70,159 |
2004-09-13 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
Director |
2023-05-03 |
1 |
2018-03-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PDLI |
PDL Biopharma Inc |
Sr. VP & CSO |
|
2004-09-13 |
4 |
AS |
$20.00 |
$400,000 |
D/D |
(20,000) |
55,820 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Sr. VP & CSO |
|
2004-10-04 |
4 |
OE |
$7.85 |
$19,625 |
D/D |
2,500 |
58,320 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Sr. VP & CSO |
|
2004-12-14 |
4/A |
OE |
$7.85 |
$39,250 |
D/D |
5,000 |
58,320 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Sr. VP & CSO |
|
2004-12-14 |
4 |
OE |
$7.85 |
$39,250 |
D/D |
5,000 |
63,320 |
|
- |
|
PDLI |
PDL Biopharma Inc |
EVP & CSO |
|
2008-07-21 |
4 |
D |
$10.98 |
$16,679 |
D/D |
(1,519) |
70,159 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Sr. VP & CSO |
|
2005-08-03 |
4 |
OE |
$7.85 |
$170,243 |
D/D |
21,687 |
70,707 |
|
- |
|
PDLI |
PDL Biopharma Inc |
EVP & CSO |
|
2008-07-14 |
4 |
D |
$10.56 |
$15,280 |
D/D |
(1,447) |
71,678 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
EVP & CSO |
|
2008-04-28 |
4 |
OE |
$7.85 |
$157,000 |
D/D |
20,000 |
73,125 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Sr. VP & CSO |
|
2004-09-13 |
4 |
OE |
$7.85 |
$78,500 |
D/D |
10,000 |
75,820 |
|
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2020-01-07 |
4 |
S |
$7.78 |
$55,627 |
D/D |
(7,150) |
87,360 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,510 |
94,510 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2019-12-23 |
4 |
AS |
$8.37 |
$334,800 |
D/D |
(40,000) |
94,510 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2019-12-23 |
4 |
OE |
$0.48 |
$19,200 |
D/D |
40,000 |
134,510 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-08 |
4 |
S |
$7.00 |
$82,712 |
D/D |
(11,816) |
140,371 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-15 |
4 |
AS |
$8.54 |
$256,200 |
D/D |
(30,000) |
140,371 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-19 |
4 |
AS |
$9.59 |
$383,600 |
D/D |
(40,000) |
140,371 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-20 |
4 |
AS |
$12.04 |
$198,443 |
D/D |
(16,482) |
140,371 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-21 |
4 |
AS |
$12.06 |
$404,227 |
D/D |
(33,518) |
140,371 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-07 |
4 |
S |
$6.76 |
$68,837 |
D/D |
(10,183) |
152,187 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-20 |
4 |
OE |
$0.48 |
$7,911 |
D/D |
16,482 |
156,853 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
75,010 |
162,370 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-15 |
4 |
OE |
$0.48 |
$14,400 |
D/D |
30,000 |
170,371 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-21 |
4 |
OE |
$0.48 |
$16,089 |
D/D |
33,518 |
173,889 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2021-01-19 |
4 |
OE |
$0.48 |
$19,200 |
D/D |
40,000 |
180,371 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
CEO and President |
|
2022-01-10 |
4 |
S |
$6.65 |
$159,095 |
D/D |
(23,924) |
185,577 |
0 |
- |
|
57 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|